FBInvestor
Stocks / Amneal Pharmaceuticals Inc
Institutional Ownership

Amneal Pharmaceuticals Inc

CUSIP 03168L105COM STK CL AAMRXQ1 2026

13D / 13G Filings
43
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
25.8%
Max % of class reported
Institutional Holders
307
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

43 filings · latest Oct 7, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Oct 7, 2025Patel Chintu13D/A8.2%SEC
2Oct 6, 2025Patel Dipan13D/A7.6%SEC
3Aug 8, 2025Patel Chirag K.13D/A7.1%SEC
4May 14, 2025Akram Mahesh13G/A6.6%913.31MSEC
5Apr 30, 2025The Vanguard Group13G5.0%15.76MSEC
6Mar 17, 2025Patel Tushar Bhikhubhai13D/A15.7%SEC
7Feb 10, 2025Ubs Group AG13G/ASEC
8Jan 23, 2025Patel Dipan13D/A7.7%SEC
9Nov 14, 2024Mahesh Akram13G/A8.8%26.86MSEC
10Oct 31, 2024Patel Chirag K.13D/A7.1%21.84MSEC

33 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Amneal Pharmaceuticals Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Blackrock, Inc.24.52M$304.77M
2Tpg Gp A, LLC12.33M$153.25M
3Rubric Capital Management LP11.04M$137.20M
4State Street Corp6.79M$84.46M
5Dimensional Fund Advisors LP5.69M$70.72M
6Morgan Stanley4.64M$57.64M
7Geode Capital Management, LLC4.55M$56.52M
8 Neuberger Berman Group LLC3.68M$45.70M
9Nuveen, LLC3.24M$40.32M
10Invesco Ltd.3.19M$39.64M